investorscraft@gmail.com

Intrinsic Value of Applied Genetic Technologies Corporation (AGTC)

Previous Close$0.00
Intrinsic Value
Upside potential
Previous Close
$0.00
* Our model cannot be used “out of the box” for the valuation of this stock. You can still do your own valuation by changing the valuation input parameters.

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2022-06-30 and quarterly data as of 2022-09-30.

  1. Annual
  2. Quarterly YoY
  3. Quarterly QoQ

Annual revenue growth rates, % (past and forecasted)

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year(a)2023202420252026202720282029203020312032203320342035203620372038203920402041204220432044204520462047

INCOME STATEMENT

Revenue growth rate, %-35.0NaN
Revenue, $0NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $m67NaN
Operating income, $m-66NaN
EBITDA, $m-64NaN
Interest expense (income), $mNaN
Earnings before tax, $m-69NaN
Tax expense, $m0NaN
Net income, $m-69NaN

BALANCE SHEET

Cash and short-term investments, $m46NaN
Total assets, $m67NaN
Adjusted assets (=assets-cash), $m20NaN
Average production assets, $m6NaN
Working capital, $m24NaN
Total debt, $m18NaN
Total liabilities, $m37NaN
Total equity, $m29NaN
Debt-to-equity ratio0.625NaN
Adjusted equity ratio-0.374NaN

CASH FLOW

Net income, $m-69NaN
Depreciation, amort., depletion, $m2NaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $m-66NaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $m-2NaN
Free cash flow, $m-64NaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $m24
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount